Patents by Inventor Richard Frederic LaBaudiniere

Richard Frederic LaBaudiniere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid Forms Of A Transthyretin Dissociation Inhibitor
    Publication number: 20160185739
    Abstract: The present invention relates to solid forms of the N-methyl-D-glucamine (meglumine) salt of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one solid form and to the therapeutic or prophylactic use of such solid forms and compositions.
    Type: Application
    Filed: December 22, 2015
    Publication date: June 30, 2016
    Inventors: RICHARD FREDERIC LABAUDINIERE, MICHAEL HENRY O'NEILL
  • Solid forms of a transthyretin dissociation inhibitor
    Patent number: 9249112
    Abstract: The present invention relates to solid forms of the N-methyl-D-glucamine (meglumine) salt of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one solid form and to the therapeutic or prophylactic use of such solid forms and compositions.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: February 2, 2016
    Assignee: PFIZER INC.
    Inventors: Richard Frederic Labaudiniere, Michael Henry O'Neill
  • SOLID FORMS OF A TRANSTHYRETIN DISSOCIATION INHIBITOR
    Publication number: 20150031735
    Abstract: The present invention relates to solid forms of the N-methyl-D-glucamine (meglumine) salt of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one solid form and to the therapeutic or prophylactic use of such solid forms and compositions.
    Type: Application
    Filed: September 12, 2012
    Publication date: January 29, 2015
    Inventors: Richard Frederic Labaudiniere, MICHAEL HENRY O'Neill
  • Treatment method using a cGMP-Specific PDE inhibitor
    Patent number: 6218400
    Abstract: A compound of formula and salts and solvates thereof, wherein R0, R1, and R2 are defined in the specification. A compound of the present invention is a potent and selective inhibitor of cGMP-specific PDE and has utility in a variety of therapeutic areas where such inhibition is beneficial.
    Type: Grant
    Filed: August 24, 1999
    Date of Patent: April 17, 2001
    Assignee: ICOS Corporation
    Inventors: Alain Claude-Marie Daugan, Richard Frederic LaBaudiniere
  • Chemical compounds
    Patent number: 6001847
    Abstract: A compound of formula ##STR1## and salts and solvates thereof, wherein R.sup.0, R.sup.1, and R.sup.2 are defined in the specification. A compound of the present invention is a potent and selective inhibitor of cGMP-specific PDE and has utility in a variety of therapeutic areas where such inhibition is beneficial.
    Type: Grant
    Filed: June 8, 1998
    Date of Patent: December 14, 1999
    Assignee: ICOS Corporation
    Inventors: Alain Claude-Marie Daugan, Richard Frederic LaBaudiniere